To become a leading player in the fast-growing health-care industry in Israel, by expending the existing operation and distribution channels, and adding new
activities, services and products to the portfolio.
Distribution
Sales & Marketing
Regulation & Licensing
Storage & Logistic
Home Medical Devices
Food Supplements
Cannabis
CBD
Omri Ofri
Managing Director, GB Pharma
20 Years of senior management and marketing roles
at Israel’s leading pharmasutical distribution companie
We provide wide and professional distribution system and sales force, covering all relevant channels, including, pharma channels, O.M.H, health funds and convenient stores. We make innovative healthcare products accessible to the Israeli consumer
During Q2024 – 1 – pharma division, launched a uniqe and innovative medical device in the israeli market-“test and drive” the only single use alcohol test in the market for drivers, the test gives aqurate indication regarding quantity of alcohol in the blood. with globrands distribution system, the product is available in all the pharma chains, convinient stores and groceries in israel.
GB pharma goal is to become a dominante player in the canabis and cbd industry ,focusing in distribution and sales servic
During 2023, GB pharma became a significant player in the medical cannabis industry by purchasing a majority in N.D.N, a medical cannabis distribution company offering services for medical cannabis,
including storage, distribution and collecting.
Our knowledge in the field of pharmaceuticals and pharmacology integrates with the realms
of CBD and cannabis in Israel
A few months ago, GB introduced the first molecular CBD Vape in Israel,
and they developed a unique molecule in collaboration with a pharmacological laboratory.
